Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C20orf194 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | HLA-DOB | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | C15orf38-AP3S2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RAB39B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MT-ATP6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | PCDHA9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | VDAC1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NCALD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DAGLA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PWP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |